Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

American Journal of Hematology(2022)10.1002/ajh.26590Source: DataRank Database

Multiple myeloma: 2022 update on diagnosis, risk stratification, and management is a research paper published in American Journal of Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 851 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access851 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: bronzeTopics (32)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

S. Vincent Rajkumar ORCID

Live enrichment

PubMed:35560063

National Institutes of Health

Grant: CA 168762

National Institutes of Health

Grant: CA 186781

National Institutes of Health

Grant: 5P50CA186781-02

Mayo Clinic Multiple Myeloma SPORE

NCI NIH HHS

Grant: P50 CA186781

NCI NIH HHS

Grant: R01 CA168762

bronzeLicense: Wiley Online Library User Agreement

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26590

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26590

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ajh.26590

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9387011

https://doi.org/10.1002/ajh.26590

Fields of Study

03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsBortezomibDexamethasoneHematopoietic Stem Cell TransplantationHumansLenalidomideMultiple MyelomaNeoplasm Recurrence, LocalRisk AssessmentTransplantation, Autologous

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsBortezomibDexamethasoneHematopoietic Stem Cell TransplantationHumansLenalidomideMultiple MyelomaNeoplasm Recurrence, LocalRisk AssessmentTransplantation, Autologous

Keywords

BortezomibAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationHumansNeoplasm Recurrence, LocalMultiple MyelomaLenalidomideRisk AssessmentTransplantation, AutologousDexamethasone

Sustainable Development Goals

SDG 3: 3. Good health